Full-Time

Clinical Team Lead

Oncology

Updated on 7/21/2026

Fortrea

Fortrea

10,001+ employees

Global CRO providing Phase I-IV trials

Compensation Overview

$135k - $142k/yr

Remote in USA + 2 more

More locations: Remote in Canada | Durham, NC, USA

Remote

Remote US or Canada based; travel up to 30% (global – primary domestic and international).

Category
Biology & Biotech (1)
Required Skills
Forecasting
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Fortrea

Find people who can refer or advise you

Requirements
  • University/college degree (life science preferred) or certification in a related allied health profession from an appropriately accredited institution; Fortrea may consider relevant and equivalent experience in lieu of educational requirements.
  • Fluent in English, both written and verbal.
  • Bachelor's degree
  • 5+ years clinical research/monitoring experience or an equivalent combination of education and experience to successfully perform key responsibilities of the job.
  • 3+ years of experience leading project teams through the start-up, study conduct, data management, analysis, close out and report writing of clinical studies.
  • Oncology experience as a Clinical Team Lead
  • Experience providing oversight to external vendors (e.g. CRO, central labs, call centers, DCT providers).
  • Working knowledge of ICH Guidelines and Good Clinical Practice including international regulatory requirements for the conduct of clinical development programs.
  • Advanced computer skills (e.g., Microsoft Word, Excel, Project, Access and Power Point).
  • Experience managing projects in a matrix and virtual environment.
  • Excellent communication, planning and organizational skills.
  • Demonstrated ability to lead by example and to encourage team members to seek solutions independently; demonstrated ability to handle multiple competing priorities and to utilize resources effectively.
  • Demonstrated ability to inspire effective teamwork and motivate staff within a matrix system.
  • Financial awareness and ability to actively and effectively utilize financial tracking systems.
  • Ability to work independently and mentor junior project team members.
  • Ability to negotiate and liaise with clients in a professional manner.
  • Ability to present to staff at all levels.
Responsibilities
  • Take accountability for proactively driving clinical project performance toward contracted deliverables while meeting customer needs and maintaining operational excellence.
  • Drive communication and collaboration with the client and project team across a matrixed, multicultural environment.
  • Lead the development of the clinical project strategy and ensures prioritization with the clinical project team and key stakeholders in the creation of clear, data driven strategies and proactive management of project scope, timelines, quality and budget. In collaboration with relevant departments, prepare and deliver presentations for new business as required.
  • Manage the operational aspects of projects to support subject recruitment and retention, clinical vendor delivery and oversee the monitoring visit strategy.
  • Identify clinical project, financial and quality risks leveraging end to end risk management practices and quality by design principles.
  • Appropriately utilize data sources, dashboards and risk management strategies to drive innovation and proactive problem solving with the project and client teams.
  • Adhere to project governance and issue escalation pathways, ensuring that clinical project plans are in place to address identified risk while adhering to professional standards, SOPs, client and regulatory requirements
  • Partner with project team members and key stakeholders to oversee and manage clinical project budgets, resources and scope.
  • Ensure adherence to established budget and financial milestones. Accountable for accurately forecasting clinical project revenue and managing project costs in adherence to the budget.
  • Leading the timely management of changes to scope and the change order process. Ensures project team awareness and tracking of KPIs for any client specific metrics.
  • Provide inspiring leadership and play a key role in the creation of high performing clinical project teams. Facilitating communication and teamwork while driving delivery, ensuring that clinical team members understand contracted scope, timelines and budget.
  • Ensures that clinical resource projections are accurate and visible to resourcing teams, proactively escalating resource constraints and challenges.
  • Develops and mentors team members in multiple areas of expertise and provide feedback as needed to respective line managers
  • As required by the project roles participate and oversee the regulatory/ethics committee submissions, tracking, and documentation.
  • Support new business with active participation in Bid Defense preparation and meetings, as required.
  • And all other duties as needed or assigned
Desired Qualifications
  • Master or other advanced degree
  • Device Experience

Fortrea is a global contract research organization that provides clinical development services for the life sciences industry. It offers full service, functional service, and hybrid outsourcing models across Phase I–IV trials, clinical pharmacology, and consulting, serving biotech, biopharma, medical devices, and diagnostics. Its work is delivered through a network of investigators and specialized teams in approximately 100 countries, supporting trial design, execution, data management, and regulatory compliance. Fortrea’s approach combines its legacy experience from Covance and Labcorp with a pureplay CRO model to deliver fit-for-purpose solutions and agile project delivery. This positions it to manage trials across more than 20 therapeutic areas with scientific rigor and operational excellence. The company aims to bring predictability to clinical trial execution and help clients turn research ideas into real-world outcomes.

Company Size

10,001+

Company Stage

IPO

Headquarters

Durham, North Carolina

Founded

2023

Get referred to Fortrea

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Barclays raised the price target to $18 on June 24, 2026, citing growing favor for diagnostic tools in healthcare subsectors.
  • Fortrea delivered $153 million gross savings in 2024 and $129.1 million Q4 operating cash flow, supporting EBITDA guidance of $190 million to $220 million.
  • Q1 2026 adjusted EBITDA of $47 million beat estimates by 35.8%, driven by cost-optimization and improved commercial execution.

What critics are saying

  • Cascading layoffs in India's Data Management teams reported July 2026 will degrade execution quality, raising client churn risk with Pfizer and Roche within 6 to 9 months.
  • Competitor Clario is aggressively pricing AI-enabled oncology platforms, undercutting Fortrea's FIT suite and threatening the $205 million EBITDA margin target within 12 to 18 months.
  • Revenue concentration among top three clients, estimated at 40%, exposes Fortrea to existential loss if one major sponsor like Vertex terminates its $1.2 billion backlog contract within 12 to 24 months.

What makes Fortrea unique

  • Fortrea launched FIT on April 7, 2026, an AI suite with three pillars improving trial speed and efficiency.
  • The company achieved a 1.14x book-to-bill ratio for three consecutive quarters, driven by biotech rebound and cost optimization.
  • Fortrea appointed Jason Knoblauch as CFO effective July 6, 2026, leveraging prior CFO experience to strengthen financial leadership.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

27%

2 year growth

27%
Connectweb Technologies, Inc.
Apr 7th, 2026
Fortrea unveils Fortrea Intelligent Technology(TM) to help sponsors and sites run Smarter, more integrated trials.

Fortrea unveils Fortrea Intelligent Technology(TM) to help sponsors and sites run Smarter, more integrated trials. Fortrea Holdings Inc AI-enhanced suite of solutions features new and improved technology to empower efficiency, confidence and quality. Highlights: * Designed to transform clinical trial operations for sponsors, sites and study teams * Persona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and quality * Builds on Fortrea's flagship platform Xcellerate(R) to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) - Fortrea (Nasdaq: FTRE), a leading global clinical research organization (CRO), today unveiled Fortrea Intelligent Technology(TM)(FIT), a suite of innovative technology solutions designed to transform clinical trial operations. By integrating persona-driven, AI-powered solutions that automate workflows, streamline oversight and elevate productivity, FIT helps enable sponsors, investigator sites and Fortrea project teams to deliver trials faster, with greater predictability, agility and quality. An Innovative, Intelligent Suite of Clinical Solutions FIT encompasses major enhancements to familiar Fortrea offerings, including the award-winning Xcellerate(R) platform, along with newly launched solutions designed to integrate all processes within the trial ecosystem. The suite boasts applications for biopharma and biotech customers across clinical pharmacology, clinical development and medical device development, and it can be deployed in both full service and functional service models, with select components available as software-as-a service (SaaS). FIT solutions are arranged into three pillars: * Lifecycle: Deliver Trials Faster with Confidence Solutions that help sponsors and sites progress clinical trials throughout each step of the clinical development journey. They help accelerate clinical trials by automating key steps, from pre-award to final eTMF. * Foresight: Turn Data into Actionable Insights Solutions that transform data into foresight, helping enable faster decision-making and proactive risk mitigation. They provide clarity, trend analysis and risk mitigation through intuitive dashboards that empower confident, near-real-time decisions and simplified oversight. * Companion: Empowering Study Teams to Work Smarter Persona-driven, AI-powered solutions that support more productive and efficient clinical trial operations. They help streamline study delivery, help boost productivity and enable collaboration. "We are at a remarkable moment in time, where the evolution of clinical trials is converging with unprecedented advancements in technology. Fortrea Intelligent Technology sits at this nexus," said Chief Information Officer Alejandro Martinez Galindo. "Built on decades of industry experience and direct sponsor and investigator site input, FIT delivers human-centered solutions that enable sponsors and sites to conduct trials more efficiently, with greater confidence and lower risk." Xcellerate(R) Anchors the Intelligent Suite Xcellerate(R), Fortrea's platform for Risk-Based Quality Management (RBQM), Central Monitoring and Oversight, is the foundation of the FIT offering. Recent enhancements deliver a modern, intuitive experience that integrates data across the trial ecosystem to provide near-real-time, role-based insights. With embedded AI and machine learning, Xcellerate(R) can analyze complex patterns, generate predictive signals and initiate automated workflows, reducing manual effort and enabling teams to focus on the critical human judgment required for successful clinical research. "We expect these Xcellerate(R) enhancements and the broader FIT platform will be game changers for our study teams and our clients," said Chief Operating Officer and President, Clinical Development Mark Morais. "Incorporating the responsible and ethical use of AI, these technologies enable a stronger research ecosystem and the ability to respond more quickly to what the data are telling us - all of which can make the difference in getting life-changing treatments to patients faster and more efficiently." Fortrea continues to expand the Fortrea Intelligent Technology portfolio, with additional solutions planned for future release. About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. Connectweb partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Its talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow Connectweb on LinkedIn, X and Bluesky. Fortrea Contacts: Jennifer Minx (Media) - 919-410-4195, [email protected] Kate Dillon (Media) - 646-818-9115, [email protected] Tracy Krumme (Investors) - 984-385-6707, [email protected]

Yahoo Finance
Apr 7th, 2026
Fortrea launches AI-powered technology suite to speed up clinical trials

Fortrea, a global clinical research organisation, has unveiled Fortrea Intelligent Technology (FIT), an AI-enhanced suite of solutions designed to transform clinical trial operations for sponsors, sites and study teams. The platform builds on Fortrea's Xcellerate system to deliver persona-driven, AI-powered solutions that automate workflows and streamline oversight. FIT is organised into three pillars: Lifecycle, which accelerates trials from pre-award to final eTMF; Foresight, providing near-real-time insights and risk mitigation through intuitive dashboards; and Companion, offering AI-powered tools to boost productivity and collaboration. The suite is available for clinical pharmacology, clinical development and medical device development, deployable in full service and functional service models, with select components available as software-as-a-service.

Yahoo Finance
Feb 26th, 2026
Fortrea reports $2.7B revenue, $190M EBITDA as book-to-bill hits 1.14x

Fortrea reported Q4 revenue of $660.5 million, down 5.2% year-over-year, and full-year revenue of $2.723 billion, up 1% and within guidance. Q4 adjusted EBITDA was $54 million, whilst full-year adjusted EBITDA reached $189.9 million. The company posted a Q4 GAAP net loss of $32.5 million. Management noted improving demand, with Q4 book-to-bill at 1.14x and backlog at $7.7 billion, driven by higher client engagement and increased biotech RFP flow. Fortrea exceeded cost-savings targets, delivering $153 million gross savings, and generated strong Q4 operating cash flow of $129.1 million. The company repurchased $75.7 million of senior notes and ended with over $600 million liquidity. For 2026, Fortrea guided revenue of $2.55–2.65 billion with adjusted EBITDA of $190–220 million.

Yahoo Finance
Feb 25th, 2026
Fortrea reports Q4 results tomorrow with revenue expected to decline 4.3% year on year

Clinical research company Fortrea Holdings reports Q4 earnings tomorrow. Analysts expect revenues to decline 4.3% year on year, following a 1.8% decrease in the same quarter last year. Last quarter, Fortrea beat revenue expectations with $701.3 million, up 3.9% year on year, and issued full-year guidance exceeding analysts' forecasts. However, the company has missed Wall Street's revenue estimates multiple times over the past two years. Analysts have largely maintained their estimates over the last 30 days. Shares have declined 36.8% over the past month, underperforming the drug development inputs and services segment, which averaged a 1.1% decline. The stock currently trades at $10.98 against an average analyst price target of $16.44.

The Associated Press
Feb 17th, 2026
Fortrea appoints Oren Cohen as chief medical officer and Scott Dove as president of Clinical Pharmacology Services

Fortrea, a global contract research organisation, has expanded its executive team with two appointments. Oren Cohen, who previously served as both chief medical officer and president of Clinical Pharmacology Services, will now focus solely on his CMO responsibilities, overseeing medical strategy, scientific leadership and governance across Fortrea's portfolio. Scott Dove has joined as president of Clinical Pharmacology Services, responsible for early clinical development solutions across Fortrea's global network. Dove brings over 25 years of drug development experience, most recently serving as chief operating officer at Aravive and holding leadership roles at PPD, Allergan and Furiex Pharmaceuticals. Both Cohen and Dove serve on Fortrea's Executive Committee. The company provides clinical trial management and consulting services across more than 20 therapeutic areas.